Effect of annual influenza immunization on antibody response in lung transplant patients

Progress in Transplantation

Volumn 19, Issue 2, 2009, Pages 153-159

  Dopp, John M ^a   Wiegert, Nicholas A ^b   Moran, John M ^a   Francois, Mary L ^c   Radford, Kelly L ^c   Thomas, Holly ^c   Love, Robert B ^d   Hayney, Mary S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Child Development Resources   (United States)

^c University of Wisconsin Health   (United States)

^d LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; FEMALE; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NONPARAMETRIC TEST; TIME; TREATMENT OUTCOME; UNITED STATES; VACCINATION; VIROLOGY;

ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME; VACCINATION; WISCONSIN;

EID: 70349257399     PISSN: 15269248     EISSN: None     Source Type: Journal    
DOI: 10.1177/152692480901900209     Document Type: Article

References (11)

1. Frost AE. Role of infections, pathogenesis, and management in lung transplantation. Transplant Proc. 1999;31(1-2):175-177. (Pubitemid 29127414)
2. Levine M, Beattie BL, McLean DM, Corman D. Characterization of the immune response to trivalent influenza vaccine in elderly men. J Am Geriatr Soc. 1987;35(7):609-615. (Pubitemid 17089048)
3. Phair J, Kauffman CA, Bjornson A, Adams L, Linnemann C, Jr. Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med. 1978;92(5):822-828. (Pubitemid 9058671)
4. Hayney MS, Welter DL, Francois M, Reynolds AM, Love RB. Influenza vaccine antibody responses in lung transplant patients. Prog Transplant. 2004;14:346-351. (Pubitemid 40444189)
5. Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, Maurer JR. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J. 2001;18: 971-976. (Pubitemid 34092871)
6. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol. 1988;127(2):353-364. (Pubitemid 18056387)
7. Gross PA, Russo C, Teplitzky M, Dran S, Cataruozolo P, Munk G. Time to peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol. 1996;3(3):361-362. (Pubitemid 26189642)
8. Sawilowsky S. Misconceptions leading to choosing the t test over the Wilcoxon Mann-WHitney test for shift in location parameter. JMASM. 2005;2005(4):598-600. (Pubitemid 43237182)
9. Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte membory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis. 1993;167:584-592. (Pubitemid 23056324)
10. Powers DC, Hanscome PJ, Pietrobon PJ. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. Vaccine. 1995;13(14):1330-1335.
11. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med. 1999;340(14):1081-1091.